Ashwani Verma
Stock Analyst at UBS
(1)
# 2148
Out of 5,358 analysts
77
Total ratings
48.57%
Success rate
4.23%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
INCY Incyte | Maintains: Neutral | 61 61 | 68.77 | -11.3% | 1 | Jun 3, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 137 152 | 125.42 | 21.19% | 8 | May 6, 2025 | |
CYTK Cytokinetics | Maintains: Neutral | 47 41 | 32.32 | 26.86% | 5 | May 2, 2025 | |
HRMY Harmony Biosciences ... | Maintains: Buy | 55 48 | 35.58 | 34.91% | 2 | Apr 28, 2025 | |
ACAD ACADIA Pharmaceutica... | Maintains: Buy | 25 22 | 21.97 | 0.14% | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 38 33 | 31.72 | 4.04% | 4 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 0.83 | 26.51% | 5 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 179 | 111.11 | 61.1% | 6 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 30 27 | 17.77 | 51.94% | 8 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 30 34 | 43 | -20.93% | 2 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 14 | 9.74 | 43.74% | 2 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 415 475 | 325.81 | 45.79% | 4 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 106 114 | 68.15 | 67.28% | 2 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 55 54 | 17.01 | 217.46% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 83 79 | n/a | n/a | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 107 105 | 111.92 | -6.18% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 28 | 33.78 | -17.11% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 76 81 | 34.97 | 131.63% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 7 | 79.74 | -91.22% | 1 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 209 | n/a | n/a | 2 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 9 12 | 8.71 | 37.77% | 2 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 0.56 | 2578.57% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 137 71 | n/a | n/a | 3 | Aug 4, 2022 |